Learn top strategies to help you boost your 340B pharmacy program and stay compliant with upcoming regulations. Join HASC and SUNRx, an Endorsed Business Partner, at a regional 340B roundtable for Southern California organizations.
With proposed federal and state legislative changes coming down the pike, 340B entities must stay agile and disciplined in managing their programs. Navigating Big Pharma’s complex 340B pricing limitations also demands that organizations fully understand the current regulatory framework.
At the roundtable, we’ll network and hear the latest information to assist your 340B program management. Our agenda for the day:
| 9:00 a.m. | Registration |
| 9:30 | Welcome and Introduction HASC Leadership and John Bretz, Director of Strategic Relations, SunRx |
| 9:30 to 10:45 | Best Practices for Specialty Pharmacy Todd Weber, Director, BioPlus Specialty Pharmacy |
| 10:45 to 11:00 | Break |
| 11:00 to 11:45 | State 340B Legislative and Regulatory Update Adam Dorsey, Group Vice President, California Hospital Association |
| 11:45 a.m. to 12:30 p.m. | Federal 340B Legislative and Regulatory Update Jeff Davis, Partner, Bass, Berry & Sims PLC |
| 12:30 to 1:15 | Networking lunch |
| 1:15 to 2:15 | Managing 340B through ESP and Advanced Claims Capture Justin Ott, Principal, Account Management, AuthorityRx |
| 2:15 | Closing statements |
The roundtable is TPA agnostic and open to all members of your 340B team.
To register or for any questions, please contact Devani Hubbard, [email protected] or (213) 538-0715. We look forward to seeing you!
Learn more about SUNRx on the company’s website.